Home | Contact Us | Log In
(888) 789-6604
Report Stack
Advanced search
Account Detail 0 items in basket
Order History Total $
Saved Searches View Basket basket
Medisyn Technologies, Inc. - Product Pipeline Review - 2014
Publication Date Oct 2014
Product Type Report
Pages 29
Single User License help $ 1500.00
Site User License help $ 3000.00
Corporate User License help $ 4500.00
 

Reportstack.com does not charge credit card fee, transaction charges, extra tax or VAT on any purchase.

Medisyn Technologies, Inc. - Product Pipeline Review - 2014

Summary

Global Markets Direct’s, ‘Medisyn Technologies, Inc. - Product Pipeline Review - 2014’, provides an overview of the Medisyn Technologies, Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Medisyn Technologies, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Medisyn Technologies, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Medisyn Technologies, Inc.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Medisyn Technologies, Inc.’s pipeline products

Reasons to buy

- Evaluate Medisyn Technologies, Inc.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Medisyn Technologies, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Medisyn Technologies, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Medisyn Technologies, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Medisyn Technologies, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Medisyn Technologies, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Medisyn Technologies, Inc. Snapshot 5
Medisyn Technologies, Inc. Overview 5
Key Information 5
Key Facts 5
Medisyn Technologies, Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Medisyn Technologies, Inc. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Medisyn Technologies, Inc. - Pipeline Products Glance 11
Medisyn Technologies, Inc. - Early Stage Pipeline Products 11
Preclinical Products/Combination Treatment Modalities 11
Discovery Products/Combination Treatment Modalities 12
Medisyn Technologies, Inc. - Drug Profiles 13
MT-103 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
MT-477 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Small Molecules to Agonize GABA Receptor for Neuropathic Pain 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
Small Molecules to Agonize GABAB Receptor for Neuropathic Pain 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
Small Molecules to Inhibit Aggregation for Alzheimers Disease 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Small Molecules to Inhibit Amyloid beta for Alzheimers Disease 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
MT-062 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Small Molecules for MRSA 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Small Molecules for Tuberculosis 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
Small Molecules to Inhibit COX-2/5-LO for Inflammation 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Small Molecules to Inhibit Protease for HIV / AIDS 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Medisyn Technologies, Inc. - Pipeline Analysis 24
Medisyn Technologies, Inc. - Pipeline Products by Target 24
Medisyn Technologies, Inc. - Pipeline Products by Molecule Type 25
Medisyn Technologies, Inc. - Pipeline Products by Mechanism of Action 26
Medisyn Technologies, Inc. - Locations And Subsidiaries 27
Head Office 27
Appendix 28
Methodology 28
Coverage 28
Secondary Research 28
Primary Research 28
Expert Panel Validation 28
Contact Us 29
Disclaimer 29

List of Tables
List of Tables
Medisyn Technologies, Inc., Key Information 5
Medisyn Technologies, Inc., Key Facts 5
Medisyn Technologies, Inc. - Pipeline by Indication, 2014 8
Medisyn Technologies, Inc. - Pipeline by Stage of Development, 2014 9
Medisyn Technologies, Inc. - Monotherapy Products in Pipeline, 2014 10
Medisyn Technologies, Inc. - Preclinical, 2014 11
Medisyn Technologies, Inc. - Discovery, 2014 12
Medisyn Technologies, Inc. - Pipeline by Target, 2014 24
Medisyn Technologies, Inc. - Pipeline by Molecule Type, 2014 25
Medisyn Technologies, Inc. - Pipeline Products by Mechanism of Action, 2014 26

List of Figures
List of Figures
Medisyn Technologies, Inc. - Pipeline by Top 10 Indication, 2014 7
Medisyn Technologies, Inc. - Pipeline by Stage of Development, 2014 9
Medisyn Technologies, Inc. - Monotherapy Products in Pipeline, 2014 10
Medisyn Technologies, Inc. - Pipeline by Top 10 Target, 2014 24
Medisyn Technologies, Inc. - Pipeline by Top 10 Molecule Type, 2014 25
Medisyn Technologies, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2014 26

Title Date Price
Europe Digital Camera Head for Endoscopes Industry 2016 Market Research Report
By QYResearch
The Europe Digital Camera Head for Endoscopes Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Digital Camera Head for Endoscopes industry. The re ...Read More
Apr 2016 $3600.00
China Pharmaceutical Guidebook Series (4) Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Imported Traditional Chinese Medicines and Natural Medicines
By Access China Management Consulting Ltd
The traditional medicines in Orient, especially, the traditional Chinese medicines are always regarded by occidental as mysterious medicines. Until today not only the chemical composition of tradition ...Read More
May 2015 $750.00
Latest Guide to Chinese Pharmaceutical GMP Regulations
By Access China Management Consulting Ltd
China possesses a fourth population in the world and has one of the largest drug markets round the world. By 2012, sales on the Chinese drug market have reached RMB 926.1billion (about US$147 billion) ...Read More
Jul 2015 $750.00
"Acne vulgaris "- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Acne vulgaris  - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of the disease and ...Read More
Apr 2016 $4950.00
"Acute coronary syndrome(ACS)"- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Acute coronary syndrome (ACS) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of th ...Read More
Apr 2016 $4950.00
"Acute heart failure(AHF)"- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Acute heart failure (AHF) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of the di ...Read More
Apr 2016 $4950.00
"Acute ischemic stroke (AIS)"- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Acute ischemic stroke (AIS) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of the ...Read More
Apr 2016 $4950.00
"Acute lymphoblastic leukemia (ALL)"- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Acute lymphoblastic leukemia (ALL) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview ...Read More
Apr 2016 $4950.00
"Age-related macular degeneration (AMD)"- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Age-related macular degeneration (AMD) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overv ...Read More
Apr 2016 $4950.00
"Alzheimer’s disease (AD)"- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Alzheimer’s disease (AD) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of the d ...Read More
Apr 2016 $4950.00

  * Required field
Name *
E-mail *
Telephone 
Company *
Country *
Query 
 
   

Published By :  Global Markets Direct

For support please
contact:
US Toll Free
+1 888-789-6604
Asia Pacific
+91-9893555190
 
 
To receive alerts about
an update, future offers and discounts on this report, signup here.
Email ID
 

Companies


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Countries


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z